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1. Introduction 
Median sternotomy is a commonly performed incision with distinct advantages for 
exposure of mediastinal and pulmonary hilar structures [1]. However, a well-defined 
incidence of wound complications is associated with sternotomy, which are costly and 
potentially lethal in cases of deep sternal wound infection (DSWI) or mediastinitis [2-13]. 
Not only is DSWI associated with significant perioperative mortality, but historically even 
successfully treated DSWI is associated with reduced mid- and long-term survival 
compared with matched cardiac surgical patients without this dreaded postoperative 
complication [7-12].  
In the past 10 years, we have accumulated extensive experience with managing DSWI as a 
referral center for these difficult problems. We and others have formalized a protocol for 
managing mediastinal infection utilizing negative pressure wound therapy which allows 
sternal salvage and improved outcomes in the majority of cases of DSWI [14-16]. This report 
describes our protocol for managing mediastinitis and presents our results for the past 18 
years. 
2. Background 
Median sternotomy was originally introduced by Milton in 1897 and was performed 
infrequently for various conditions of the mediastinum until cardiac surgery as a field 
blossomed in the 1950s [17]. Shumacker first suggested median sternotomy as the procedure 
of choice for approaches to the heart and great vessels [18] since it avoided the significant 
pain and other complications, primarily pulmonary- or pleural-based, of the bilateral 
anterior thoracotomy (“clamshell”) incision, which was most frequently used up to that 
point. However, not until Julian and colleagues demonstrated discrete advantages of the 
median sternotomy incision for cardiac surgery, particularly improved surgical efficiency, 
excellent exposure the heart, great vessels, and pulmonary hila, and reduced pulmonary 
trauma, was a convincing argument for median sternotomy as the incision of choice for 
cardiac surgical procedures put forth [19 Table 1]. The utility of this incision, the ease and 
speed of performance, and the common nature of surgically-treated cardiovascular and  
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RIGHT ATRIUM +++ ++ 0 
RIGHT VENTRICLE +++ + + 
LEFT ATRIUM +++ + + 
LEFT VENTRICLE ++ 0 +++ 
SVC +++ ++ 0 
IVC +++ ++ 0 
ASC AORTA/root +++ + + 
RIGHT SCA ++ ++ 0 
INNOMINATE +++ ++ 0 
LEFT SCA + 0 +++ 
DESC AORTA 0 0 +++ 
Main PA +++ 0 ++ 
RIGHT PA ++ +++ 0 
LEFT PA ++ 0 +++ 
PROX TRACHEA ++ + + 
ESOPHAGUS 0 +++ ++ 
HEMIDIAPHRAGM ++ + + 
MAIN STEM 
BRONCHI 
0 +++ ++ 
Table 1. Comparison of exposure of various intrathoracic anatomic structures through 
median sternotomy, right thoracotomy, or left thoracotomy. (+++ denotes excellent, reliable 
exposure; 0 denotes no reliable exposure) 
thoracic diseases in multiple populations approached through this incision are factors 
which combine to make median sternotomy the most commonly performed osteotomy 
worldwide [20]. Recently, several alternatives to median sternotomy have been promoted, 
including thoracoscopic and robotic approaches to cardiac and thoracic procedures [21, 
22]. These approaches are possible as a result of high fidelity instrumentation and video 
platforms but are limited by steep learning curves and expense. Therefore, for most 
hospital systems performing cardiac surgical procedures, median sternotomy remains the 
mainstay incision.  
3. Definition and classification 
There is still no universally accepted method for treatment of DSWI or other sternal wound 
complication. One possible explanation for this is that until relatively recently, thorough 
classification schemes providing specific criteria for assignment as deep sternal infection, 
mediastinitis, superficial infection, or sterile sternal dehiscence were lacking. However, it is 
important to distinguish between these individual entities since each demands a different 
management strategy. Furthermore, results of reported series which include a variety of 
wound complications will differ from those that report a homogenous population. For 
example, sternal wound infections that are limited to the superficial soft tissues obviously 
demand less aggressive intervention for treatment and will generally respond more readily 
to treatment than deep sternal infection with higher likelihood for success. Therefore, when 
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comparing different treatment modalities for sternal wound infection, it is important to be 
clear about the extent of infection, since heterogeneity could skew reported results. 
Two prominent classification schemes have been proposed and are in use. Mediastinal 
dehiscence or the more chronic form, sternal nonunion, is defined as sternal wound 
disruption without any evidence for infection either clinically or pathologically [23, 24]. 
These entities will not be discussed in any detail. In contrast, mediastinitis, as characterized 
by the U.S. Centers for Disease Control and Prevention (CDC), is an infection of the 
mediastinum diagnosed by isolation of pathogenic organisms from the mediastinal fluid or 
tissue especially when there is obvious evidence of infection at the time of sternal 
exploration [25]. Alternatively, a combination of clinical features including chest pain, 
sternal drainage with bony instability, fevers, radiographic findings such as widened 
mediastinum, and bacterial isolation may also warrant a diagnosis of mediastinitis. 
Obviously, from the surgical perspective, these definitions are somewhat lacking since 
either superficial infections, confined to the soft tissues, or deep infections, involving the 
bone and/or retrosternal space could produce bacteremia and clinical signs of severe 
infection [23].  
Fortunately, more descriptive classification schemes have been introduced and provide 
more specific insight into the pathologic involvement of the sternal tissues and the clinical 
consequences and course [23, 26, 27]. For example, the classification scheme introduced by 
El Oakley and Wright is based on the time at which the patient presents with 
mediatiastinitis relative to the initial surgical procedure [23]. Schulman et al have advocated 
a similar classification system [27]. In addition, the El Oakley description also accounts for 
relevant risk factors underlying the clinical scenario and whether or not previous attempts 
to treat the sternal wound infection have been made and failed [Table 2]. Therefore, five 
distinct categories of infection are described, each with important treatment implications. 
For example, the subtypes I and II appear to respond well to primary sternal closure with 
mediatinal irrigation, while subtypes III-V appear to require more aggressive sternal 
debridement and repair techniques [23]. 
 
Classification Description of Infection 
Type 1 Mediastinitis within 2 weeks of operation 
without risk factors 
Type 2 Mediastinitis between 2 and 6 weeks of 
operation without risk factors 
Type 3a Type 1 with one or more risk factors 
Type 3b Type 2 with one or more risk factors 
Type 4a Type 1, 2, or 3 after one failed therapy 
Type 4b Type 1, 2, or 3 after more than one failed 
therapy 
Type 5 Mediastinitis presenting 6 weeks or more 
after operation 
Table 2. Classification scheme of mediastinitis introduced by El Oakley and Wright based on 
the time at which the patient presents with mediatiastinitis relative to the initial surgical 
procedure (modified from El Oakley and Wright [23]).  
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The classification by Jones et al differs from that of El Oakley and Wright in that it is more 
descriptive anatomically and physiologically [26, TABLE 3]. Three different “types” of 
sternal infection are described, encompassing both superficial and deep infections, and 
based on the degree of underlying tissue involvement with infection. We have preferred the 
use of this classification system as it is simpler to use since it based strictly on features 
observed or encountered at the time of initial sternal exploration. In addition, Type 3b is 
physiologically meaningful since it denotes the patient who is systemically ill from the 
sternal wound process. In our own institutional experience of 222 adult cardiac surgical 
patients treated for postoperative DSWI, approximately 50% of patients exhibited 
septicemia (Jones 3b) upon initial presentation [14]. 
 
Class Depth of Involvement Description 
1a Superficial Skin/subcutaneous tissue dehiscence 
1b Superficial Exposed deep fascia, sutures intact 
2a Deep Exposed bone, stable wired sternotomy 
2b Deep Exposed bone, unstable wired 
sternotomy 
3a Deep Exposed necrotic or fractured bone, 
unstable, heart exposed 
3b Deep Types 2 or 3 with septicemia 
Table 3. Mediastinal wound classification system modified from Jones et al [26]. Although 
anatomic involvement by infection in distinguished, the presence of septicemia is the most 
important feature clinically. 
4. Risk factors and pathophysiology 
Multiple different etiologies for development of DSWI have been invoked over time. For 
example, most infections were traditionally thought to arise as a result of breaks in proper 
surgical technique, prompting strict guidelines for sterile surgical technique. In addition, 
secondary involvement the mediastinum from remote sites such as leg incisions or the 
pulmonary tree has also been suggested as a mechanism for DSWI. The “endogenous 
pathway,” seeding of the mediastinum from other host sources, does appear to be important 
in the development of S. aureus mediastinitis. To illustrate, Jakob et al showed that nasal 
carriage of S. aureus was an independent predictor of sternal infection postoperatively [28], 
while others have demonstrated that application of mupirocin to the nares of S. aureus 
colonized individuals can help reduce postoperative infection [29]. More recently, other factors 
have been recognized as important contributors to cardiac surgical site infections. For instance, 
the appropriate timing of perioperative antibiotics and strict perioperative glucose control are 
both associated with reduced surgical wound infectious complications [30, 31].  
Several different patient-related factors have been repeatedly implicated in the development of 
DSWI, most consistently obesity and diabetes mellitus [5, 6, 32, TABLE 4]. Eklund et al and 
others have observed that increasing severity of obesity elevates the risk for surgical site 
infection in a step-wise fashion [6, 13, 33]. Furthermore, when obesity is described in terms of 
percentage body fat, the relationship between obesity and surgical site infection is nearly linear 
and appears more accurate than use of body mass index as a descriptor of obesity [34]. 
Potential explanations for relationship between obesity and DSWI include technical problems  
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Study # Patients Identified Risk Factors 
Milano CA, et al. 
Circulation 1995 [9] 
6,459 Obesity, NYHA class, redo surgery, CPB duration 
Toumpoulis IK, et al. 
Chest 2005 [55] 
3,760 Diabetes, preoperative hemodynamic instability, 
renal failure, bilateral IMA, sepsis and/or 
endocarditis  
Immer FF, et al. Ann 
Thorac Surg 2005 [94] 
5,690 Obesity, diabetes mellitus, COPD, bilateral IMA 
Fowler G, et al. 
Circulation 2005 [13] 
300,000 Obesity (BMI of 30-40 kg/m2), diabetes, previous 
MI, urgent operative status, hypertension 
Prabhakar G, et al. Ann 
Thorac Surg 2002 [32] 
559,004 Obesity 
Sjorgren J, et al. Ann 
Thorac Surg 2005 [90] 
4,826 Diabetes, obesity, reduced EF, renal failure, multi-
vessel CAD 
Olsen MA, et al. J Thorac 
Cardiovasc Surg 2002 
[10]  
1,980 Obesity (BMI>30 kg/m2), diabetes, > 4 units RBC 
transfusion, IABP, current smoking 
Cayci C,et al. Ann Plast 
Surg 2008 [52] 
7,978 Obesity (BMI>30 kg/m2), diabetes, urgent 
operation, recent smoking; h/o CVA, total HLOS, 
sepsis/endocarditis postop 
Risnes I, et al. Ann 
Thorac Surg 2010 [12] 
18,352 COPD, obesity (BMI > 30 kg/m2), blood 
transfusion, advanced age, male sex, diabetes 
Table 4. Compiled analyses for underlying risk factors associated with sternal wound 
infection. Obesity and diabetes mellitus are consistently shown to be independent predictors 
of poststernotomy mediastinitis. 
during surgery owing to the patient’s size, increased bleeding, increased deadspace in the 
wound, and ineffective or inadequate dosing of perioperative antibiotics [6, 9]. 
Although multiple mechanisms for sternal wound complications are proposed, it is widely 
accepted that reduced sternal perfusion, often by virtue of internal mammary artery (IMA) 
harvesting for use as a vascular conduit in coronary artery revascularization, is one of the 
most important causes of sternal nonhealing and infection [1-6, 8, 26], especially when both 
IMAs are harvested for bypass graft surgery [5]. Therefore, more cases of DSWI appear to 
occur after coronary artery bypass grafting or after combined procedures that include 
coronary artery surgery [7, 35]. Other viable explanations for DSWI etiology include poor 
bone stock from osteoporosis, malnutrition, and other factors; poorly performed sternotomy 
leading to sternal fractures and/or costosternal disassociation; and other patient related 
factors including peripheral vascular disease and lung disease [8, 36]. Several other factors 
have been implicated in the development of DSWI but may not be manifest in the context of 
a retrospective review or randomized trial because the numbers are too low. For example, it 
is generally accepted that postoperative steroids or chronic immunosuppression increases 
risk for DSWI, but this has been difficult to demonstrate in even large database reviews [13, 
37]. Finally, Risnes et al have demonstrated in a review of over 18,000 consecutive patients 
undergoing coronary artery surgery in Norway, the major preventable risk factor associated 
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Several risk analyses are available to estimate the individual patient’s propensity for 
developing DSWI. For example, using Society of Thoracic Surgery National Cardiac 
Database information, Fowler et al created a model to estimate the risk for systemic infection 
after coronary artery bypass surgery using patient characteristics available preoperatively 
[13]. The Fowler model also provides for inclusion of important intraoperative details 
known to influence postoperative infection including the need for intra-aortic balloon 
counterpulsation and prolonged cardiopulmonary bypass times [13]. Although the model 
devised by Fowler et al was based on various cases of major infection after coronary artery 
surgery, including DSWI, the authors did validate the model as predictive of infection in a 
test population from the STS Database, and the model was also recently validated in a 
different cohort of patients from the UK as being predictive of DSWI [38]. The EuroSCORE 
system also has been shown to predict infection and associated mortality with acceptable 
discrimination [39]. 
5. Incidence 
Despite advancements in most aspects of perioperative care, rates of sternal wound 
complications, including mediastinitis, following adult cardiac surgery have varied little 
over the past 30 years [2-6], although incremental reduction in single center rates of DSWI 
have been noted and attributed to adjunctive measures such as strict perioperative glucose 
control [40]. As noted previously, rates of DSWI vary with regard to the specific definition 
used to describe the pathology encountered and the patient population studied. In general, 
reported rates of DSWI are relatively low, ranging from 0.25% to 3.6 % [2-9, 38, 39, 41, 42]. 
However, the incidence of superficial sternal infection excedes that of deep sternal infection 
by as many as three times [10, 41, 43], and Francel has stated that as many as 70% of patients 
with poststernotomy infection will have superficial tissue involvement [44]. 
6. Diagnosis 
Depending on the virulent nature of the sternal wound infection, patients typically present 
within 30 days of cardiac surgery. The most common symptoms include sternal wound 
drainage, sternal instability, fever, and malaise. In many cases, a high index of suspicion is 
required to establish the diagnosis, especially when classic signs and symptoms are absent. 
In addition, it is often difficult to distinguish on physical examination the difference 
between deep sternal wound infection (infection present beneath the sternum) and 
superficial sternal infection. Therefore, early wound opening and inspection with 
appropriate sampling of tissue for bacteriologic assessment is strongly encouraged when 
sufficient clinical suspicion exists. 
One of the most reliable signs of DSWI is sternal instability, which frequently implies a 
deeper problem than can be appreciated at the superficial level [44]. While sternal instability 
can be tested on physical examination, we have often noted that the patient themselves will 
typically report sternal clicking with inspiration, cough, or various other physical 
maneuvers, so this information should be thoughtfully considered if DSWI diagnosis is 
being entertained.  
The use of various radiographic examinations is often encouraged when evaluating for DSWI, 
and, in fact, is included as part of the CDC guidelines for defining mediastinitis [25]. Formerly, 
PA and lateral chest radiograph was the investigative procedure of choice, where details such 
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as a “sternal stripe” indicated present of air between the two sternal halves. The lateral 
displacement of one or more sternal wires, secondary to tearing of the wire through one side of 
the sternum, has been a frequently noted finding in the case of poststernotomy infection [37]. 
More recently, chest computed tomography has been suggested as the procedure of choice for 
assessing sternal wound infection when a diagnosis cannot be established by clinical 
examination alone [45, 46]. Mediastial fluid collections, free gas bubbles, soft tissue swelling, 
pleural effusions, sternal dehiscence, and subcutaneous fluid collections have been the 
predominant CT findings in cases of DSWI [47], but these features appear to be more specific 
and sensitive for DSWI presenting more than 3 weeks after surgery [48]. 
7. Morbidity and mortality 
Mediastinal infection negatively impacts early, mid-term, and long-term survival after adult 
heart surgery [2, 7-12]. While it is intuitive that clinically serious DSWI reduces 30-day 
and/or in-hospital survival relative to similar patients not suffering this complications, the 
effect of DSWI on long-term survival is especially insulting since many patients referred for 
heart surgery expect to gain a survival advantage compared with other treatment options 
for their underlying heart disease [49].  
Prior to the development of modern protocols for DSWI management, which include 
thorough sternal debridement and use of vascularized flaps to repair the mediastinal defect 
resulting from debridement, early mortality from DSWI exceeded 50% [50]. In the “modern 
era,” reported rates of in-hospital or 30-day DSWI mortality for range from 7% to over 30% 
[11,14, 35, 42, 51, 52]. In our own recent experience, early mortality for DSWI is 
approximately 16% [14]. Therefore, despite many advancements in intensive care medicine, 
DSWI continues to be a deadly complication. Death in the early period is typicaly the result 
of sepsis or other infectious complications including multiorgan failure [12]. Morisaki et al. 
recently demonstrated methicillin-resistent S. aureus infection to be an independent risk 
factor for in-hospital mortality in their cohort of poststernotomy DSWI patients [53].  
Patients surviving infectious complications and the acute insult of DSWI exhibit reduced 
mid-term survival compared with controls. For example, one-year mortality for DSWI 
following CABG is significantly increased compared with similar patients who did not 
develop DSWI [2, 8, 10]. Milano et al and Braxton et al both demonstrated a doubling of 
mid-term mortality among patients with DSWI after CABG compared with controls [9, 54]. 
Karra et al examined predictors of one-year mortality after treatment for DSWI and found 
that delay in closing the mediastinal defect; age over 65 years; need for ICU care prior to 
sternal debridement; and methicillin-resistent S. aureus infections were each independently 
associated with mortality [7]. 
Long-term survival has consistently been demonstrated to suffer in patients with a history 
of poststernotomy DSWI [5, 8, 9, 12, 35, 52, 54-56, Figure 1]. For example, Filsoufi et al 
reviewed nearly 5,800 adult heart surgery patients at a single institution over 8 years and 
found DSWI to be associated with significantly reduced 5-year survival compared with 
patients who did not develop DSWI [35]. Similarly, Risnes et al reviewed their experience of 
over 18,000 cardiac surgical patients with a mean follow-up of over 10 years. Long-term 
survival for patients whose course was complicated by DSWI was <50% compared with 
>70% for patients without DSWI, and DSWI was independently associated with reduced 
long-term survival after cardiac surgery [HR 1.59; 95% CI 1.16 – 2.70, p = 0.003] [12]. Similar 
data have been also been reported by Toumpoulis et al. [55].  
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Fig. 1. From Braxton et al with permission [8], patients suffering mediastinal infection after 
coronary artery bypass grafting have worse overall long-term survival compared with 
similar patients not experiencing the complication.  
It is unclear as to the specific reasons for worse long-term survival after DSWI is successfully 
treated, but cardiac-related deaths or progression of cardiovascular disease appears to be a 
common cause of death for those with DSWI [8, 12]. In addition, Chu et al recently reported 
that patients with peripheral vascular disease had worse outcomes long-term after coronary 
artery surgery [57]. We recently evaluated long-term survival in a cohort of 222 adult 
cardiac surgical patients treated at Duke University Hospital for poststernotomy 
mediastinitis. Using multivariable regression analysis and at a mean follow-up of 5.5 years, 
the following variables were noted to be independently associated with survival: heart 
failure [Hazard ratio (HR) 1.58, p = 0.029]; sepsis [HR 2.38, p <0.001]; peripheral vascular 
disease [HR 2.06, p = 0.001], age > 65 years [HR 1.61, p = 0.037]; and take back for bleeding 
[HR 2.96; p = 0.007] (unpublished data).  
Not only does DSWI lead to increased mortality among post-surgical patients, it is also 
closely associated with other types of postoperative complications. For example, in a recent 
review of morbidity following coronary surgery from the Virginia Cardiac Surgery Quality 
Initiative, DSWI was the not only the most expensive complication, but it was also 
associated with a longer length of hospital stay, by more than two full weeks, than any other 
single postoperative complication, including perioperative stroke and renal failure [4]. Other 
reports have corroborated the impact of DSWI on overall hospital length of stay [2, 6, 52]. 
Speir et al also demonstrated that DSWI was the most likely form of postoperative 
morbidity to be associated with other complications such as prolonged ventilation, bleeding, 
renal failure, and atrial fibrillation [4]. DSWI has also been associated with increased rates of 
stroke, need for inotropic or mechanical cardiac support, and perioperative myocardial 
infarction, renal failure, and prolonged mechanical ventilation [12, 51].  
8. Microbiology 
Numerous bacterial pathogens may contribute to DSWI, but the most commonly isolated 
organisms are Staphylococcus, either coagulase-negative Staphylococcus (CNS) or S. aureus 
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[58]. In our own recently described experience, methicillin-sensitive and methicillin-resistent 
S. aureus each accounted for 35% of wound isolates, while CNS was present in 12%, and 
gram negative organisms were found in 18% [14]. It is noteworthy that our protocols for 
preoperative preparation of the cardiac surgical patient do not routinely incorporate 
mupirocin treatment. Additionally, many patients included in our cohort of patients treated 
for DSWI underwent primary cardiac surgery at referring facilities. Therefore, specific 
details in these patients predisposing to a certain pathogen were often lacking. Risk factors 
for the development of methicillin-resistent S. aureus poststernotomy mediastinitis include 
previous hospitalization and takeback for bleeding after the original cardiac surgical 
procedure [59]. Gardlund et al have attributed the development of S. aureus infection to the 
development of bacteremia [60], which is corroborated by our own data in which 50% of 
patients treated for DSWI had evidence of bacteremia or septicemia (Jones classification 3b) 
at the time of clinical presentation with DSWI [14]. Finally, it has been demonstrated that 
methicillin-resistent strains of S. aureus are more virulent and deadly than methicillin-
sensitive strains, and, in fact, methicillin resistance was the only independent predictor of 
early mortality in one analysis [61].  
In contrast, S. epidermidis often presents with a rather indolent course, often not manifesting 
clinically until 3 weeks or more postoperatively [62]. CNS is frequently isolated in cases of 
sternal instability or nonunion, which may itself arise from obesity or acute or chronic 
pulmonary disease [60]. CNS has recently been noted to of increasing incidence and has 
been reported to be present in roughly 50% of sternal infections in some series [6, 11, 60].  
Gram negative organisms contribute less commonly to the pathogenesis of DSWI. Gram-
negative infections of the mediastinum classically arise in the setting of other postoperative 
infectious complications such pneumonia, urinary tract infections, intra-abdominal 
infections, or other nosocomial infections [58, 60]. Mekontso-Dessap et al reviewed their 
experience with DSWI after cardiac surgery and found that Enterococcus species were the 
most common isolates in early cases of DSWI (<14 days), which likely arise from 
translocation of these bacteria from other sources in the host [63]. In contrast, Staphylococcus 
species, often CNS, were the most common isolates in cases presenting more remotely from 
the original surgery [63]. 
9. Cost of DSWI 
One of the most impactful consequences of DSWI is the costs incurred in its management, in 
part due to the multiple associated conditions that frequently complicate the clinical picture of 
these sick patients [4, 12]. The average hospital costs for patients treated for DSWI is 
approximately 2.5 to 3 times that of similarly matched patients who enjoy an uncomplicated 
postoperative course [23, 64, 65]. As noted, increased costs are primarily attributed to 
associated comorbid conditions that arise during the treatment of mediastinitis, increased 
length of hospital stays, including frequent need for ICU services, and the need for multiple 
surgical procedures when using traditional approaches to DSWI [4, 23]. For example, 
Hollenbeak et al found that patients with DSWI remained hospitalized an average of 3 weeks 
longer than noninfected patients after coronary artery surgery [2]. Interestingly, in the same 
study it was noted that DSWI patients who ultimately expired incurred nearly $61,000 US 
dollars more in costs than other DSWI patients who ultimately survived, presumably 
secondary to the multiple comorbidities associated with clinically aggressive mediastinitis [2]. 
Using more recently acquired information, Speir et al found that mediastinitis was the single 
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most costly complication in Virginia after coronary artery surgery, raising the cost of care by 
over $62,000 US dollars, or more than 240% increase, on average, [4].  
Therefore, it is apparent that treatment of these critically ill patients is extremely 
expensive to the hospital system, even if the complication is uncommonly encountered. 
As a result, and based on increased scrutiny of various hospital-associated conditions, the 
US Center for Medicare and Medicaid Services no longer reimburses for hospital costs 
incurred in treatment of DSWI following coronary artery bypass surgery [66]. 
Interestingly, however, it appears that use of negative pressure therapy in the treatment 
of DSWI contains associated costs. For example, Mokhtari et al reported the use of VAC 
therapy to be cost effective and efficacious in eradicating mediastinal infection [65]. In our 
own experience, patients treated with negative pressure therapy for DSWI had costs that 
were $150,000 US dollars less than the average Medicare charges for treatment required 
for DSWI ($152,00 vs. $ 300,000) [67].  
10. Treatment of DSWI 
Upon establishing the diagnosis of sternal wound infection, the immediate goal of treatment 
is complete eradication of infection followed by stabilization of the sternum and chest wall. 
Multiple strategies for managing mediastinitis have been proposed and range from open 
mediastinal packing to debridement with closure over drains, to placement of vascularized 
tissue flaps. In addition, negative pressure therapy (NPT) has been used to aide in the 
treatment of mediastinal infection, as first reported in 1999 [68]. Several initial series 
described the use of NPT for treating mediastinitis and outlined potential benefits of this 
approach to controlling mediastinal infection [15, 16, 45, 69, 70]. However, a consensus as to 
best treatment for mediastinal infection has yet to be established. For example, Schimmer et 
al recently surveyed 79 cardiac surgery programs in Germany to query DSWI management 
strategies [71]. They found that approximately 1/3 of the centers preferentially used NPT for 
controlling mediastinal contamination, while another 1/3 use closed chest irrigation, and 
another 1/3 combine management approaches [71]. Other groups continue to advocate 
more aggressive surgical therapy in addressing infected sternal wounds [7, 72].  
Initially, the primary treatment for DSWI was open packing followed by secondary closure 
[73]. This method was labor intensive, cumbersome, and was characterized by significant 
rates of recurrent infection and other complications [58]. Shortly thereafter, Schumaker and 
Mandelbaum proposed early closure over drains [74], which allowed continual irrigation of 
the infected mediastinum [73, 74]. Although this approach represented an improvement 
relative to open packing procedure, the latter procedure was still associated with failure 
rates of at least 25% [73].  
Omental flap repair of the infected mediastinum was originally reported in 1976 by Lee [75] 
and has been shown to have distinct advantages over continuous antiobiotic irrigation 
through drains [76] and over muscle flaps for sternal wound defect repair [9, 14]. This is 
thought to occur by obliterating dead space, a mechanism that can also be credited to 
muscle flap repair of the open mediastinum [26]. However, the omentum may have 
angiogenic and immunologic properties that stimulate more complete sternal defect healing 
[58]. Other advantages of using the greater omentum to flap the sternal defect include 
superior malleability and excellent blood flow. As originally described, traditional omental 
flap repair of the mediastinum involves a laparotomy to mobilize and place the graft 
through the anterior portion of the diaphragm [Figure 2]. More recently, harvesting the  
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Fig. 2. Preparation of the omental flap graft for transfer to the mediastinum from Milano et 
al with permission [80]. After preparation of the mediastinum [A], a laparotomy is 
performed and the greater omental graft is prepared by mobilizing it from the transverse 
colon [B]. Once the graft is tunneled through an anterior diaphragm incision, it is secured in 
the mediastinum to fill the defect. Care is taken to avoid twisting or kinking the omental 
graft as it is delivered from the abdomen into the mediastinum [C]. The mediastinum is then 
closed over drains with retention sutures. The drains are placed to bulb suction [D]. 
omental pedicle using a laparoscopic approach may have advantages over open abdominal 
procedures and has been utilized successfully [77].  
Jurkiewicz et al first reported on the successful use of muscle flaps in DSWI in 1980 [78], 
while the Emory groups’ experience with muscle flap repair of the infected mediastinum 
refined approaches and clarified advantages of these techniques [26]. As with omental 
flap repair, discrete advantages of complete mediastinal repair with vascularized muscle 
flaps were demonstrated as compared with closed chest irrigation [26, 79]. Milano et al 
compared omental and pectoralis muscle flap repairs for the infected mediastinum and 
found that procedural details, early complications, and hospital length of stay were all 
improved with omental flap repair [80]. Omental flap repair also trended towards 
improved survival and reduced chronic pain when compared with pectoralis flap 
procedures [80]. In fact, significant long-term complications can be associated with muscle 
flap repair of the mediastinum including paresthesias, sternal instability, truncal 
weakness, and prolonged pain syndromes [9, 26, 81, 82]. Reporting on the long term 
results of muscle flap coverage of the mediastinum, Ringelman noted persistent pain in 
over 50% of patients, numbness and paresthesias in 44%, sternal instability in over 40%, 
and shoulder weakness in 1/3 of patients [82]. It is worth noting, however, that 
unfavorable outcomes with open packing and/or mediastinal irrigation prompted 
recommendations for aggressive mediastinal debridement including radical sternectomy 
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[78, 83]. While effective in removing devitalized and infected tissue, the resulting sternal 
defect required large-volume vascularized tissue such as muscle flaps or large omental 
flaps to obliterate deadspace. As a result, many of the negative long-term consequences 
often experienced and attributed to muscle flap repair may actually have originated with 
radical sternal debridement. After the introduction of NPT management of mediastinal 
sepsis/infection, radical sternal debridement has been de-emphasized [14, 16, 83, 84]. 
Stated differently, the use of NPT to treat the infected mediastinum helps to avoid radical 
sternal debridement and likely avoids chronic syndromes previously seen and perhaps 
erroneously attributed to treatment methods.  
Obdeijn et al introduced the use of negative pressure therapy (NPT) for treatment of the 
infected mediastinum after median sternotomy [68]. The introduction of vacuum-assisted 
closure (VAC®) technology [Kinetic Concepts Inc. USA San Antonio, TX], based on the 
application of negative or subatmospheric pressure to the wound, has improved 
management of DSWI, as demonstrated by several groups including our own, and is now 
considered a cornerstone in the management of these complex clinical scenarios [14, 15, 70, 
73]. Negative pressure therapy appears to induce effective proliferation of the effectors of 
wound healing [85] removes wound exudates, improves regional blood flow [86], and 
reduces accumulation of inflammatory mediators such that earlier and more complete 
wound healing results [70]. Laboratory studies also show that NPT induces early wound 
healing through microdeformations within the wound, stimulating cell division, 
proliferation, and angiogenesis [73, 87]. One distinct advantage of the mechanisms of NPT is 
more thorough eradication of infection, stimulation of vigorous wound granulation, and the 
subsequent promotion of safe and effective sternal closure either primarily or with rigid 
osteosynthesis [11, 14, 88]. Wound treatment with NPT appears to be significantly lower 
rates of recurrent wound complications such as reinfection, seromas, or hematomas [14, 89, 
90]. However, there is a recognized tendency for recurrent infection when MRSA is the 
inciting organism or with prolonged mechanical ventilation [91].  
Clinically, NPT has been associated with significantly lower mortality rates in the acute 
management of mediastinitis [11, 89]. For instance, Petzina et al recently compared 118 
patients with poststernotomy DSWI and demonstrated that patients treated with NPT had 
better survival and less sternal re-infection compared with patients in whom NPT was not 
used [89]. In addition, as may have been expected, shorter hospital stays were noted within 
the NPT group. Baillot et al reported similar results by, while documenting a reduction in 
acute DSWI mortality from 14.1% to less than 5% when NPT was incorporated into 
treatment regimens [11]. Finally, De Feo et al evaluated 157 patients with poststernotomy 
DSWI at a single institution over 15 years. Patients in whom NPT was incorporated in the 
treatment regimen had reduced early mortality rates and, reduced reinfection rates, and 
slightly reduced overall hospital stays [92].  
As noted previously, long term mortality among patients with DSWI has been historically 
poor compared with similar patients not suffering the complication, but recent evidence 
suggests this may be changing. The first evidence for this phenomenon was reported by 
Sjogren et al, who compared 46 patients with poststernotomy mediastinitis managed with 
NPT with a matched cohort of cardiac surgical patients not experiencing postoperative 
mediastinitis [93]. Actuarial and adjusted 5-year survival was not different between groups, 
demonstrating for the first time that long-term results of heart surgery were not negatively 
impacted by DSWI [Figure 3].  
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Fig. 3. Actuarial (panel A) and adjusted (panel B) survival curves for patients with 
poststernotomy mediastinitis treated with vacuum-assisted closure (VAC) as compared to 
control subjects who did not experience mediastinitis after heart surgery. No difference in 
long-term survival was demonstrated between the groups. From Sjogren et al [93], with 
permission. 
Another study from the UK demonstrated that midterm survival for patients with 
postoperative mediastinitis was similar to patients not suffering the complication [51]. 
Similar results have been reported by Cayci et al from Columbia University, who found 
that DSWI was associated with increased early mortality but long-term survival was not 
different from controls. Furthermore, DSWI was not an independent predictor of 
mortality in their single-center experience [52]. It is unclear as to why this may be the 
case, but it is notable that NPT was used in over 80% of patients with mediastinitis as a 
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means for clearing infection, and nearly 50% of patients in their cohort were managed 
with vac therapy alone or vac + secondary sternal closure. In our own series, we found 
that use of NPT for controlling mediastinal infection was an independent predictor of 
survival on multivariable analysis [unpublished data], and that patients managed with 
NPT had significantly improved long term survival compared with patients not treated 





Fig. 4. Kaplan Meier survival curves for patients with poststernotomy mediastinitis treated 
with negative pressure therapy (NPT) or by traditional means for controlling mediastinal 
infection (controls). Patients treated with NPT had significantly improved long-term 
survival by log rank analysis. 
11. Suggested treatment algorithms for DSWI 
While accumulating extensive experience with DSWI management as a referral center for 
these difficult problems. We and others have formalized protocols for managing mediastinal 
infection utilizing NPT which allows sternal salvage and improved outcomes in the majority 
of cases of DSWI [14-16, Figure 5].  
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Fig. 5. Suggested algorithm for management of mediastinal infection after cardiac surgery 
via median sternotomy, with permission from Sjogren et al [15]. Emphasis is placed on 
gentle sternal debridement, negative pressure therapy to the mediastinum, and closure 
based on monitored serum C-reactive protein levels. 
As noted previously, successful treatment of DSWI begins with recognition of signs and 
symptoms of sternal infection, which may occasionally be subtle. Sternal wound exploration 
to ensure a prompt and accurate diagnosis is warranted when signs of mediastinitis are 
present. This approach also helps to distinguish between superficial and deep sternal 
infections. At the time of initial sternal exploration, tissues and fluid should be obtained for 
bacteriologic analysis. Targeted antibiotic therapy for 4-6 weeks duration is prescribed and 
is determined by the culture results [14, 15]. If the infectious process extends beneath the 
facial layer, all sternal hardware should be removed. The sternum itself is then gently 
debrided of grossly devitalized tissue, but wide excision of the sternum is not necessary and 
may be injurious and counterproductive. Limited sternal debridement is now preferred and 
good results have been seen with this approach [14, 16, 83, 93, 94]. Negative pressure 
therapy is then instituted on the opened incision after limited sternal debridement. The 
polyurethane foam is subsequently changed in the operating room or at the bedside every 2-
3 days. During this time, assessment as to the state of the sternum is made to determine if 
mediastinal flap repair is required or if secondary sternal closure is possible. Our general 
approach for determining when the sternum can reliably be reapproximated is based on the 
state of the sternum after several days of NPT. Wound characteristics precluding secondary 
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sternal reapproximation include multiple transverse sternal fractures, poor bone stock, 
costosternal separation, or the requirement for such extensive sternal debridement that 
reapproximation of the sternal halves is not feasible. Gustafsson en et al have advocated use 
of serum C-reactive protein levels to guide wound closure timing [95, Figure 6]. C-reactive 
protein levels less than 70 mg/L corresponded with successful sternal reapproximation [95]. 
Successes have also been reported with sternal plating as a treatment for the fractured 
sternum [11, 96], but our approach has been conservative in this regard since any residual 
infectious process could contaminate the implanted hardware [91].  
Numerous clinical advantages for DSWI management protocols incorporating NPT have 
been observed, many centered upon the sternal stabilization achieved when vacuum-
assisted clousure is engaged [70]. The sternal stability afforded by NPT improves pain 
compared with open packing or other approaches for addressing the infected mediastinum 
[88]. In addition, the stabilized sternum yields several pulmonary benefits, the first of which 
is the ability to successfully separate from mechanical ventilation. This promotes earlier and 
more effective patient mobilization and prevents the patient from being confined to bed, 
where other complications common to DSWI therapy are often incurred [70]. Negative 
pressure therapy also improves ventilation and overall pulmonary function and leads to 
more effective chest physiotherapy [70, 97]. Importantly, no deleterious hemodynamic 
effects of NPT have been documented although this has been speculated [70].  
12. Complications of treating mediastinitis 
It has been estimated that approximately 15% of patients develop recurrent infection [98]. 
In the experience of Bapat et al, this has included recurrent infection with the same 
organism associated with the original sternal infection [99], and we speculate that if the 
polyurethane foam required for NPT is not adequately inserted with each dressing 
change, small, isolated spaces may arise within the wound that can become superinfected. 
We recently reported rates of recurrent wound complications associated with various 
mediastinal flap coverages. For example, muscle flap repair of the treated mediastinum, 
consisting predominantly of pectoralis muscle flaps, was associated with increased rates 
of recurrent wound complications such as hematoma, seromas, and recurrent infection 
[14]. Conversely, use of NPT prior to definitive repair of the sternal wound defect was 
associated with increased rates of successful secondary sternal closure without the need 
for any flap transfer, and with shortened length of hospital stay after definitive repair. 
Excellent results have been reported elsewhere when NPT is incorporated into 
management protocols for DSWI [65]. 
Petzina et al recently reported a 7.2% rate of “major complications” associated with NPT for 
DSWI in a cohort of 69 patients. Most complications were bleeding-related [100]. On the 
other hand, cardiac function and hemodynamics appear to be stable during NPT to the open 
mediastinal wound [101, 102]. 
When NPT is used, caution should be exercised with regard to the length of therapy. In our 
own experience, prolonged use of NPT leads to a “frozen” mediastinum, making 
subsequent closure by vascularized flaps or other technique difficult to perform and places 
the cardiac structures at risk for injury during subsequent sternal repair. Others have noted 
the similar difficultiess [99]. In such cases, continued application of NPT to closure by 
secondary intent may be the best therapeutic option rather than to place the mediastinal 
structures at risk for injury during attempted flap repair. 
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13. Can mediastinitis be prevented? 
Loop has stated: “prevention and better treatment of sternal wound complications must be a 
major goal in assuring the highest quality of cardiovascular care…[5]. Although most efforts 
towards DSWI have focused on the treatment of DSWI, several methods to reduce rates of 
mediastinitis have been proposed and validated recently. As a result, efforts to prevent 
mediastinal infection may already be working. For instance, investigators from Boston 
recently reported on their experience with DSWI between 1992 and 2006, separating analysis 
into early and late time periods. They noted that DSWI had decreased from 1.57% to 0.88% 
over the last 5 years of their analysis and attributed the positive findings to adoption of strict 
glucose control algorithms [40]. Tight glycemic control appears to be effective in 
significantly reducing rates of DSWI. [30, 103]. In addition, Lazar et al demonstrated 
improved coronary surgery outcomes with a strategy for strict glucose control (125 – 200 
mg/dL) using glucose-insulin-potassium solution, including reduced ischemic events and 
improved rates of wound infection in a cohort of diabetic patients undergoing CABG [31]. 
Antimicrobial therapy has also positively impacted rates of DSWI. Most notably, 
appropriate timing and selection of preoperative antibiotics has been associated with 
reduced rates of sugical site infection [6, 104]. Furthermore, use of nasal mupirocin in 
patients undergoing cardiac surgery via median sternotomy eradicates 95 – 100% of S. 
aureus for up to one year postoperatively [105], and sternal wound infections are also 
reduced by nearly 2/3 in some series with the use of mupirocin in patients colonized with S. 
aureus [106, 107]. 
Technical details of the median sternotomy incision and closure almost certainly impact the 
likelihood for DSWI postoperatively. Baskett et al have argued that assiduously following 
technical details and proper surgical and aseptic techniques can also dramatically reduce 
rates of poststernotomy infection [42]. They emphasize the importance of accurate 
reapproximation of the sternal halves and caution against the use of bone wax to gain 
sternal hemostasis [42]. Since sternal instability is often evoked as one mechanism 
contributing to the development of sternal infection, evaluation of the most effective sternal 
closure methods has been undertaken. For example, Schimmer et al compared standard 
closure techniques by transsternal or peristernal wiring with techniques using additional 
lateral wire reinforcement in the method described by Robicsek in a cohort of 815 high-risk 
patients [108]. There were no differences observed in the rates of sternal dehiscence or 
superficial or deep sternal wound infections, but they did show that more sternal wires 
placed for closure was associated with significantly reduced rates of DSWI [108]. Others 
have emphasized that rigid sternal closure techniques are preferred, particularly in those 
considered at high risk for sternal wound complications such as dehiscence and infection. 
These techniques are widely used in most surgical practices that incorporate osteotomy 
incisions. In fact, cardiac surgery is now the only discipline not routinely repairing 
osteotomies with rigid plating techniques [109]. Lee et al recently reported their experience 
with titanium plate fixation of the sternum in 750 patients at high risk for sternal wound 
complications, noting 97.6% freedom from sternal infection or dehiscence [110]. Levin et al 
have also introduced another form of rigid sternal closure as an alterntive to wire circlage 
and highlighted advantages to this approach [111]. Although rigid sternal closure 
techniques have not been compared prospectively with wire circlage, cadaveric studies have 
shown rigid plate fixation techniques to be superior to wire circlage by providing increased 
stiffness to the wound closure and less lateral displacement of the sternal halves [112]. 
www.intechopen.com
 
Special Topics in Cardiac Surgery 300 
Other suggested techniques for reducing the incidence of DSWI include ensuring true 
midline sternotomy as this is thought to preserve periosteal blood flow and limits 
transverse sternal fractures which contribute to sternal nonunionn and instability [42, 44]. 
Since sternal ischemia is thought to play an important role in most cases of DSWI, limiting 
the length of internal mammary artery harvested for use as a coronary artery bypass 
conduit or avoiding its use altogether in prohibitively high risk patients may help to 
reduce DSWI [44]. Harvesting the internal mammary artery as a skeletonized conduit is 
also preferable to harvesting the graft as a pedicle since this preserves more peristernal 
blood flow [113]. Finally, sternal foreign bodies that may impede bony union, especially 
bone wax, should be avoided [42, 44]. In contrast, vancomycin paste or gentamicin-soaked 
absorbable sponges applied to the sternum upon closure have been shown to reduce rates 
of sternal bacterial contamination [114, 115]. However a more recent randomized 
controlled trial evaluating the impact of gentamicin-soaked collagen sponge on 
poststernotomy wound infection did not show an advantage of this approach over 
controls [116]. 
Based on the aforementioned successes with NPT in the treatment of documented DSWI we 
and others have recently evaluated the application of NPT to clean, closed incisions as a 
method to prevent complications in high-risk wounds [117, 118]. We initially applied this 
form of “well wound therapy” in a cohort of 57 adult cardiac surgery patients known to be 
at increased risk for DSWI based on a validated risk stratification model [13]. No cases of 
superficial or deep sternal wound infections were noted although the group had an 
estimated 6% risk for DSWI [118]. This form of NPT was noted to be easy to apply, well-
tolerated by the patients, and was also judged to be cost-effective when utilized in patients 
with increased demonstrated risk for DSWI [117]. Since the time of the original report, we 
have used this novel wound treatment system in over 200 high risk patients and continue to 
observe reduce rates of sternal wound complications (unpublished data). However, residual 
problems have been encountered with gross technical errors including off-center sternal 
incisions, sternal fractures, and costo-sternal separation.  
The mechanisms underlying such positive clinical findings are not well understood, but 
based on well described mechanisms of vacuum-assisted therapy in open incisions, it is 
hypothesized that applying NPT to the closed incision also favorably affects wound 
perfusion. Therefore, we assessed peristernal perfusion after median sternotomy and under 
various degrees of reduced native sternal perfusion as a result of mammary artery 
harvesting using laser Doppler flowmetry, demonstrating that after median sternotomy and 
IMA harvesting, peristernal perfusion is significantly reduced and recovers little in the first 
4 postoperative days [119]. However, NPT applied to the closed incision increases 
peristernal perfusion compared with controls regardless of the status of the ipsilateral IMA, 
providing a rare piece of physiologic evidence for the efficacy of NPT and supports use of 
NPT as a form of “well wound therapy,” particularly in patients at high-risk for sternotomy 
complications [119] These findings are clinically important and relevant, implying that NPT 
can augment peristernal soft tissue perfusion made relatively ischemic by IMA harvesting. 
Although this study does not address bony perfusion, per se, Fokin et al proposed that 
substrate diffusion through peristernal tissues may be an important mechanism to maintain 
perfusion in sternal wounds rendered ischemic by mammary artery harvesting until 
collateral blood supply to the sternum is well-established [120, 121]. If so, NPT may indeed 
augment sternal and/or periosteal perfusion via improved peristernal “diffusion” through 
improved soft tissue perfusion. 
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14. Conclusions 
Deep sternal wound infections remain dreaded and deadly complications associated with 
cardiac surgery. However, incremental improvements have been made recently with regard 
to lowering rates of observed infections due to a variety of measures. In addition, it appears 
that management of DSWI with negative pressure therapy alleviates the impact of this 
condition on short- and long-term survival. Further investigation is needed to determine the 
potential impact of negative pressure therapy on closed incisions as a novel method to 
prevent sternal wound complications. 
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